It serves as a defined tool for studying pancreatic beta-cell function, hypothalamic control of feeding, gastrointestinal motility, and metabolic responses in experimental systems
Oral GLP-1 medications add convenience and skip the needle but typically require strict daily timing to maximize absorption, and real-world adherence varies from person to person
In SUSTAIN-7, a study comparing semaglutide to dulaglutide in patients with inadequately controlled T2DM, a greater reduction in body weight was observed with 0.5 mg semaglutide (4.6 kg, standard error [SE] 0.28) compared with 0.75 mg dulaglutide (2.3 kg, SE 0.27) (estimated treatment difference [ETD] 2.26 kg, 95% CI 3.02 to 1.51
A Comprehensive, Clinically Led Approach Pure Impact forms part of a comprehensive, medically led plan to support effective weight loss while protecting health and structure
Optimizes fat metabolism and aids in breaking down stubborn fat stores